Center for Drug Evaluation and Research (CDER), USFDA United States of America (USA)

Research

Date range: 1 April 2021 - 31 March 2022

Parent institution:Office of Medical Products and Tobacco, USFDA

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Center for Drug Evaluation and Research (CDER), USFDA published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Center for Drug Evaluation and Research (CDER), USFDA
Count Share
2 0.04

Outputs by subject (Share)

Outputs by subject
Subject Count Share
2 0.04

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
1.15 1.25 2.42 1.14 2.14

Compare Center for Drug Evaluation and Research (CDER), USFDA with other institutions

Relationships

Affiliated joint institutions and consortia